BNGOWのチャート
BNGOWの企業情報
| symbol | BNGOW |
|---|---|
| 会社名 | |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Biotechnology: Laboratory Analytical Instruments |
| 業種 | ― |
| 概要 | 事業概要 -- |
| 本社所在地 | -- |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | -- |
| 市場名 | -- |
| ipoyear | 2018年 |
| 従業員数 | - |
| url | ― |
| nasdaq_url | https://www.nasdaq.com/symbol/bngow |
| adr_tso | ― |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 2.75 |
| 時価総額（marketcap） | 0 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
BNGOWのテクニカル分析
BNGOWのニュース
Thinking about buying stock in Summit Therapeutics, Gossamer Bio, Xpeng, BioNano Genomics, or Canopy Growth Corp? 2022/12/06 15:51:00 Benzinga
NEW YORK , Dec. 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SMMT, GOSS, XPEV, BNGO, and CGC. … Full story available on Benzinga.com
Pardes, Bionano top healthcare gainers; Gossamer, Checkpoint lead losers pack 2022/12/06 15:00:09 Seeking Alpha
Pardes Biosciences (PRDS) +19%. Bionano Genomics (BNGO) +9%. Gossamer Bio GOSS -68%. Checkpoint Therapeutics (CKPT) -23%.
Bionano Genomics Inc. (BNGO) is an excellent investment, but the stock is overvalued/undervalued right now 2022/12/06 14:54:00 US Post News
Bionano Genomics Inc. (NASDAQ:BNGO) closed Monday at $2.00 per share, down from $2.09 a day earlier. While Bionano Genomics Inc. has underperformed by -4.31%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BNGO fell by -41.18%, with highs and lows ranging from $4.35 to $1.16, whereas […]
Bionano Genomics to acquire biotechnology firm Purigen Biosystems (NASDAQ:BNGO) 2022/11/29 10:38:37 Seeking Alpha
Genome analysis solutions provider Bionano Genomics (BNGO) has agreed to acquire biotechnology company Purigen Biosystems for up to $64M, including $32M cash paid at closing
Is the Bionano Genomics Inc. (NASDAQ:BNGO) stock an investment opportunity? 2022/11/28 17:40:00 US Post News
Bionano Genomics Inc. (BNGO)’s stock is trading at $2.12 at the moment marking a fall of -4.73% from the last session close. As of this writing, shares are priced at -51.38% less than their 52-week high of $4.35, and 82.33% over their 52-week low of $1.16. Based on the past 30-day period, the stock price […]
Thinking about buying stock in Summit Therapeutics, Gossamer Bio, Xpeng, BioNano Genomics, or Canopy Growth Corp? 2022/12/06 15:51:00 Benzinga
NEW YORK , Dec. 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SMMT, GOSS, XPEV, BNGO, and CGC. … Full story available on Benzinga.com
Pardes, Bionano top healthcare gainers; Gossamer, Checkpoint lead losers pack 2022/12/06 15:00:09 Seeking Alpha
Pardes Biosciences (PRDS) +19%. Bionano Genomics (BNGO) +9%. Gossamer Bio GOSS -68%. Checkpoint Therapeutics (CKPT) -23%.
Bionano Genomics Inc. (BNGO) is an excellent investment, but the stock is overvalued/undervalued right now 2022/12/06 14:54:00 US Post News
Bionano Genomics Inc. (NASDAQ:BNGO) closed Monday at $2.00 per share, down from $2.09 a day earlier. While Bionano Genomics Inc. has underperformed by -4.31%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BNGO fell by -41.18%, with highs and lows ranging from $4.35 to $1.16, whereas […]
Bionano Genomics to acquire biotechnology firm Purigen Biosystems (NASDAQ:BNGO) 2022/11/29 10:38:37 Seeking Alpha
Genome analysis solutions provider Bionano Genomics (BNGO) has agreed to acquire biotechnology company Purigen Biosystems for up to $64M, including $32M cash paid at closing
Is the Bionano Genomics Inc. (NASDAQ:BNGO) stock an investment opportunity? 2022/11/28 17:40:00 US Post News
Bionano Genomics Inc. (BNGO)’s stock is trading at $2.12 at the moment marking a fall of -4.73% from the last session close. As of this writing, shares are priced at -51.38% less than their 52-week high of $4.35, and 82.33% over their 52-week low of $1.16. Based on the past 30-day period, the stock price […]
Bionano Genomics: Little Clinical Utility And A Whole Lot Of Burn (NASDAQ:BNGO) 2022/10/18 18:07:09 Seeking Alpha
Bionano''s Saphyr has very limited utility in the clinical setting and the basic research market is too small for the company to achieve cashflow positivity. See here why we rate BNGO a Sell.
Bionano Genomics Lags On This Crucial Metric 2022/10/13 14:06:52 The Street
There''s only one way to succeed in lab hardware. Despite a promising platform, Bionano Genomics remains a long way from sustainable success.
Bionano Genomics Inc. (BNGO) Has A Promising Outlook For 2022 2022/10/11 15:30:00 Marketing Sentinel
Bionano Genomics Inc. (NASDAQ:BNGO) has a beta value of 2.25 and has seen 4.13 million shares traded in the last trading session. The company, currently valued at $623.54M, closed the last trade at $1.97 per share which meant it lost -$0.01 on the day or -0.51% during that session. The BNGO stock price is -218.78% … Bionano Genomics Inc. (BNGO) Has A Promising Outlook For 2022 Read More »
Stocks Ease Back from Solid Gains 2022/10/05 14:24:00 Baystreet Canada
Equities in Canada’s largest market opened lower on Wednesday after a two-day rally, with gold miners and technology stocks leading the declines as bond yields rose after U.S. private payrolls data suggested resilient demand for labour. The TSX Composite dumped 187.81 points, or 1%, to open Wednesday at 19,183.18. The Canadian dollar slumped 0.87 cents to 73.16 cents U.S. In individual company news, Link Administration received a bid of A$1.27 billion ($825.37 million U.S.) from Canada''s Dye & Durham (D&D) for its corporate markets and banking segments, days after D&D''s takeover offer for the entire company fell through. DND shares fell 44 cents, or 2.7%, to $16.19. On the economic slate, Statistics Canada announced building permits increased 11.9% in August to $12.5 billion. Both the residential sector (+12.0% to $8.4 billion) and non-residential sector (+11.8% to $4.0 billion) saw strong gains, with Ontario causing much of the increase. Also in August, Canada''s merchandise exports decreased 2.9%, while imports fell 1.7%.
Stocks Hand Back Nearly 2 Days of Gains 2022/10/05 14:24:00 Baystreet Canada
U.S. stocks fell on Wednesday, giving back some of its sharp gains from the last two sessions as Treasury yield rose. The Dow Jones Industrials descended 305.23 points, or 1%, from Tuesday’s lofty perches to 30,011.09. The S&P 500 docked 52.66 points, or 1.4%, to 3,738.27. The NASDAQ Composite dropped 206.51 points, or 1.9%, to 10,969.90. Bionano Genomics saw its shares jump after the company published a study on using optical genome mapping to investigate liver cancer. Goldman Sachs slid after Atlantic Equities downgraded both stocks due to the potential of declining investment banking volume. General Motors shares dipped after Morgan Stanley lowered its price target on the stock. Private payrolls increased by 208,000, ADP said in its latest report, topping a Dow Jones estimate. Traders are still looking ahead to Friday’s release of the nonfarm payrolls report. The U.S. trade deficit fell slightly more than expected in August to its lowest level in more than a year, the Bureau of Economic Analysis reported Wednesday.